
Golidocitinib 1-hydroxy-2-naphthoate is a derivative of Golidocitinib, an oral, мощный, селективный ингибитор of Janus киназы 1 (JAK1) with an IC50 of 70 nM. It exhibits enhnaced antitumor activity and can be used for the treatment of cancer, including peripheral T клетка lymphoma (PTCL).
Golidocitinib 1-hydroxy-2-naphthoate is a derivative of Golidocitinib, an oral, potent, selective inhibitor of Janus kinase 1 (JAK1) with an IC50 of 70 nM. It exhibits enhnaced antitumor activity and can be used for the treatment of cancer, including peripheral T cell lymphoma (PTCL).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.